• <ruby id="v2d2t"></ruby>
      
<strong id="v2d2t"></strong>
        
    

  
  
        
    
        
      
      
        
              
        
    
        
  
        

  
  
        
    
        
      
    
        
      
  
        

  
  
  

  
    
        
      
        
          
        
              
        
                    
                    
                    
        
                      
        
                                                                                                          
        
            
        
        
        
            
        
        
        
        
            Like2291
            2019-07-03 15:59
            IP：重慶
        
        
    
        
    
        
        ◆◆
        
        
            
            
        
                1.Arzneimittel Forschung/Drug research 1986 36(2)，p291-303.
2.The use of antithrombotic drugs in artery disease
3. Jonassen IB, Havelund S, Ribel U, et al. Insulin Degludec is a new generation ultra-long acting basal insulin with a unique mechanism of protraction based on multi-hexamer ormation [J]. Diabetes, 2010, 59(Suppll): All(39-OR).
4.Korsatko S, Deller S, Zahiragic S, et al. Ultra-long-acting insulin degludec: two different formulations (U100 and U200) are bioequivalent and show similar pharmacodynamics [abstract no. 2349-PO]. Diabetes. 2011;60 Suppl:A624.
5.Technology Reports of the Osaka University, , vol. 7, p. 177,182。
				     [更多]
            
        
        
        
        
        
        
            
            
        
                
        
                    
        
                        
        懸賞
        
                        
        
                            
        ￥50.00
        
                            
        已托管
                                
        
                        
        
                        載入中...
                    
        
                    
                        
        
            
        
        
        
    
        

                                                                
        
            
        
        
        
            
        
        
        
        
            Like2291
            2019-06-26 09:11
            IP：重慶
        
        
    
        
    
        
        ◆◆
        
        
            
            
        
                1、Drugs Fut 1989, 14(9): 875
ISSN 0377-8282
Copyright Clarivate Analytics
CCC: 0377-8282
DOI: 10.1358/dof.1989.014.09.103408
2、Dionne, G. (BioChem Pharma Inc.); 1,3-Oxathiolane nucleoside analogues. EP 0526253; JP 1995500317; US 5538975; WO 9303027 .
3、Hoshi, A.; Casta?er, J.; Capecitabine. Drugs Fut 1996, 21, 4, 358
4、Indian Journal of Chemistry, Section B: Organic Chemistry Including Medicinal Chemistry, 1997, vol. 36, # 9, p. 816 - 818
5、DETERMINATION OF CLENBUTEROL HYDROCHLORIDE BY SEQUENTIAL INJECTION ANALYSIS COUPLED WITH CHEMILUMINESCENCE DETECTION
6、[Bioanalytic examination and pharmacokinetics of captopril. Bioequivalence studies of different captopril-containing Tensiomin preparations].
7、Agrati A. M., De Bartolo G., Palmieri G., Minerva Med., 83, 533-536(1992)
8、Dawes J., Hodson B. A., Pepper D. S., Thromb. Haemost, 62, 945-949(1989)
9、with mercury(II) diacetate,trifluoroacetic acid .
Acta Chimica Hungarica  1986 vol.122  3-4   p261-272

				
				     [更多]
            
        
        
        
        
        
        
            
            
        
                
        
                    
        
                        
        懸賞
        
                        
        
                            
        ￥90.00
        
                            
        已托管
                                
        
                        
        
                        載入中...
                    
        
                    
                        
        
            
        
        
        
    
        

                                                                
        
            
        
        
        
            
        
        
        
        
            冬候鳥(niǎo)斯伯格
            2019-06-12 11:37
            IP：重慶
        
        
    
        
    
        
        ◆◆
        
        
            
            
        
                ①從任務(wù)主手中獲取指定年報數量的年報文件（PDF）
②將年報中“利潤或合并利潤”、“研發(fā)或研發(fā)投入”、“行業(yè)產(chǎn)品地區收入”、“治療領(lǐng)域”、“產(chǎn)銷(xiāo)量”、“產(chǎn)品研發(fā)投入明細”等數據填入相應表格中（任務(wù)主提供填寫(xiě)模板）
③要求仔細認真，有責任心。
④價(jià)格2.5元/份年報預計252份，一人84份（210元），3人共計630元。
⑤若審核發(fā)現有錯填、漏填，以每漏填，錯填一個(gè)數據1元計量扣除賞金
⑥以前合作做過(guò)類(lèi)似項目的優(yōu)先考慮，如有感興趣的威客可聯(lián)系參與。
				
				     [更多]
            
        
        
        
        
        
            
            
        
                
        懸賞：
        
                
         
            
        
        
        
        
        
            
            
        
                
        
                    
        
                        
        懸賞
        
                        
        
                            
        ￥630.00
        
                            
        已托管
                                
        
                        
        
                        載入中...
                    
        
                    
                        
        
            
        
        
        
    
        

                                                                
        
            
        
        
        
            
        
        
        
        
            water125310
            2019-06-04 17:12
            IP：廣州
        
        
    
        
    
        
        ◆◆
        
        
            
            
        
                USP39的Calcium Gluconate和Calcium Gluconate Injection標準，要求翻譯為中文
				     [更多]
            
        
        
        
        
        
            
            
        
                
        懸賞：
        
                
         
            
        
        
        
        
        
            
            
        
                
        
                    
        
                        
        懸賞
        
                        
        
                            
        ￥100.00
        
                            
        已托管
                                
        
                        
        
                        載入中...
                    
        
                    
                        
        
            
        
        
        
    
        

                                                                
        
            
        
        
        
            
        
        
        
        
            Like2291
            2019-05-16 17:10
            IP：重慶
        
        
    
        
    
        
        ◆◆
        
        
            
            
        
                1.論批生產(chǎn)記錄設計的有效性對產(chǎn)品質(zhì)量追溯的影響——以公司內膠囊及片劑產(chǎn)品批生產(chǎn)記錄為例
2.Federal Health bulletin 4（1961）12:189 需要這個(gè)文獻
3.Morton RF, et al. Studies on the absorption, diffusion, and excretion of cycloserine. 
Antibiot Annu 1955-56; 3: 169-72. 
4.Acta Gastroenterol Belg.1969,32（10）：771-777 A NEW ANTISPASMODIC DRUG IN THE TREATMENT OF BILIARY AND INTESTINAL DISCASCS:A CLINICAL TEST.
5.a process for preparing (S)-1-(3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)prop-2-en-1-one
https://priorart.ip.com/IPCOM/000238343
				     [更多]
            
        
        
        
        
        
        
            
            
        
                
        
                    
        
                        
        懸賞
        
                        
        
                            
        ￥50.00
        
                            
        已托管
                                
        
                        
        
                        載入中...
                    
        
                    
                        
        
            
        
        
        
    
        

                                                                
        
            
        
        
        
            
        
        
        
        
            Doris_huan
            2019-05-13 10:39
            IP：重慶
        
        
    
        
    
        
        ◆◆
        
        
            
            
        
                簡(jiǎn)介：藥智人才是最專(zhuān)業(yè)的醫藥產(chǎn)業(yè)招聘平臺，與許多醫藥行業(yè)的知名企業(yè)都有合作，職位種類(lèi)豐富，崗位更專(zhuān)業(yè)~

賺取賞金規則（活動(dòng)時(shí)間：5月13日-5月17日）：
1.免費注冊/登錄藥智人才（https://job.yaozh.com/），上傳簡(jiǎn)歷：
簡(jiǎn)歷完善度≥80 可獲得50元賞金；
2.簡(jiǎn)歷完成后，并截圖藥智人才簡(jiǎn)歷板塊的完善度提交審核，并且備注藥智人才的用戶(hù)名/注冊手機信息；
3.審核通過(guò)后，賞金會(huì )在3個(gè)工作日內審核并發(fā)放，如提交后有刪除簡(jiǎn)歷的行為，視為作弊處理，對應賞金將會(huì )被凍結不予提現。
4.特別福利：簡(jiǎn)歷完善后既有機會(huì )直接內推給名企噢~

溫馨提示：
1.如果疑問(wèn)可以聯(lián)系客服QQ：3413833812
2.一經(jīng)發(fā)現求職者在上傳簡(jiǎn)歷期間有作弊等行為，藥智人才將取消其賞金并凍結該筆提現。
3.在法律允許的范圍內，本活動(dòng)一切解釋權歸藥智人才

下期活動(dòng)預告
活動(dòng)日期：5月20-5月24日
賞金金額：更多賺取賞金細則5月20日揭曉噢~
				
				
				
				
				     [更多]
            
        
        
        
        
        
            
            
        
                
        懸賞：
        
                
         
            
        
        
        
        
        
            
            
        
                
        
                    
        
                        
        懸賞
        
                        
        
                            
        ￥500.00
        
                            
        已托管
                                
        
                        
        
                        載入中...
                    
        
                    
                        
        
            
        
        
        
    
        

                                                                
        
            
        
        
        
            
        
        
        
        
            Like2291
            2019-04-28 15:40
            IP：重慶
        
        
    
        
    
        
        ◆◆
        
        
            
            
        
                1.丙氨酰谷氨酰胺及其注射液的研究開(kāi)發(fā)
2.A prospective multicentre study on the treatment of cardiovascular risk factors and claudication symptoms in patients with peripheral artery disease (the IDOMENEO study).
Cimminiello C, Arpaia G, Polo Friz H, Boracchi P, Marano G, Spezzigu G, Visonà A.
Vasa. 2015 Sep;44(5):371-9. doi: 10.1024/0301-1526/a000456.
3.2013 International Conference on Materials
Engineering, ICMEN 2013
4.Orientation of substitution in the aromatic series. XVIII. Sulfonation of phenol by chlorosulfonic acid in solvents
5.Mechanism of reaction of chlorosulfonic acid with some aromatic compounds
6.Arzneimittelforschung. 1982;32(3):248-51.
In vitro--in vivo correlation, a time scaling problem? Basic considerations on in vitro dissolution testing.
7.Oral treatment with the Crataegus special extract WS 1442 inhibits cardiac hypertrophy in rats with DOCA-salt or aortic banding induced hypertension
				     [更多]
            
        
        
        
        
        
        
            
            
        
                
        
                    
        
                        
        懸賞
        
                        
        
                            
        ￥70.00
        
                            
        已托管
                                
        
                        
        
                        載入中...
                    
        
                    
                        
        
            
        
        
        
    
        

                                                                
        
            
        
        
        
            
        
        
        
        
            Like2291
            2019-04-28 11:59
            IP：重慶
        
        
    
        
    
        
        ◆◆
        
        
            
            
        
                1.Nakashima M, Morita J, Aizawa K. Pharamacokinetics and safety of
tebipenem pivoxil fine granules, an oral carbapenem antibiotic, in
healthy male volunteers. Jpn J Chemother. 2009;57(S–1):90–94
2.Baba S, Yamanaka N, Suzuki K, et al. Clinical efficacy, safety
and PK-PD analysis of tebipenem pivoxil in a phase II clinical
trial in otolaryngological infections. Jpn J Antibiot.
2009;62:155–177
3.Sunakawa K. Pharmacological properties and clinical performance
of the novel oral carbapenem antimicrobial drug, “Tebipenem
pivoxil” (Orapenem fine granules 10% for pediatric use). Jpn J
Chemother. 2009;57:279–294
4.Yamanaka N, Furukawa M, Furuya, et al. Clinical efficacy of
tebipenem pivoxil (ME1211), a novel oral carbapenem, in otolaryngological
infections, a Phase II clinical trial (1). 45th Intersci
Conf Antimicrob Agents Chemother (ICAAC) 2005; Abstract
L-577
5.Iwata S, Ouchi K, Iwata N, et al. An open clinical study of tebipenem
pivoxil in children with bacterial pneumonia. Jpn J Chemother.
2009;57(S–1):137–150
				     [更多]
            
        
        
        
        
        
        
            
            
        
                
        
                    
        
                        
        懸賞
        
                        
        
                            
        ￥50.00
        
                            
        已托管
                                
        
                        
        
                        載入中...
                    
        
                    
                        
        
            
        
        
        
    
        

                                                                
        
            
        
        
        
            
        
        
        
        
            Like2291
            2019-04-16 10:07
            IP：重慶
        
        
    
        
    
        
        ◆◆
        
        
            
            
        
                1、Atropine and scopolamine
premedication – Pharmacological aspects
and present use in Finland
2、Identification and purity test of heparin by NMR - a summary of two years' experience at the Medical Products Agency
By: McEwen I; Amini A; Olofsson I M
3、Atti della Accademia Nazionale dei Lincei, Classe di Scienze Fisiche, Matematiche e Naturali, Rendiconti
4、49-12 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 1. Absorption, Distribution and Excretion in Rats after Single …
S Takeda, E Ono, Y Matsuzaki… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri …
5、49-13 Metabolic Fate of Triethylenetetramine dihydrochloride (Trientine hydrochloride, TJA-250) 2. Metabolism study in Rats Using 14C-TJA 250
S Takeda, E Ono, Y Wakui… - Oyo Yakuri …, 1995 - [Sendai, Japan: Oyo Yakuri …     [更多]
            
        
        
        
        
        
        
            
            
        
                
        
                    
        
                        
        懸賞
        
                        
        
                            
        ￥50.00
        
                            
        已托管
                                
        
                        
        
                        載入中...
                    
        
                    
                        
        
            
        
        
        
    
        

                                                                
        
            
        
        
        
            
        
        
        
        
            wangjie453347735
            2019-04-09 11:25
            IP：重慶
        
        
    
        
    

                                                                
        <1...1920212223...42>
        
                                                    
        

                    
        
                    
        
                        
        
                            
        
                                
        發(fā)布需求,坐等藥智客上門(mén)
        
                                
        
                                    
          
                                        
        • 㒂安全可靠，先驗收再正式付款
          • 
                                        
        • 㕞性?xún)r(jià)比超高，節省一半費用
          • 
                                        
        • 㕊80%的需求得到了圓滿(mǎn)解決
          • 
                                    
        
                                    立即發(fā)布需求
                                
        
                            
        
                        
        
                        
        
                            
        
                              
                              推薦任務(wù)
                            
        
                                                    
        
                        
        
                            
        
                                                                
        
                                    
                                
        
                                                                
        
                                    
                                
        
                                                                
        
                                    
                                
        
                                                                
        
                                    
                                
        
                                                                
        
                                    
                                
        
                                                            
        
                        
        
                    
        
                
        
            
        

          
        
        
        
    
        


        
    

        






    
    
    

    








    
91国语精品自产拍在线观看_欧洲精品无码一区_国产欧美一区二_久久精品人妻中文系列

        

            3. <ruby id="v2d2t"></ruby>
          
<strong id="v2d2t"></strong>